HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $120 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating for Instil Bio (NASDAQ:TIL) and maintained a price target of $120, indicating confidence in the company's future performance.
September 17, 2024 | 11:01 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating for Instil Bio and maintained a $120 price target, suggesting a positive outlook for the company's stock.
The reiteration of a Buy rating and a high price target by a reputable analyst firm like HC Wainwright & Co. is likely to boost investor confidence in Instil Bio, potentially leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100